Conference Review

Update on mitochondrial stabilizers

Also from the Angiogenesis, Exudation, and Degeneration meeting, emerging treatments for nAMD and MacTel2, and a marker for anti-VEGF success in ROP.

AAO highlights: ILM peel in DR and more

Standout Retina Subspecialty Day 2022 talks include real-world faricimab and high-dose aflibercept results, and Protocol T outcomes.

Comparing techniques for RRD, MH

Prime cuts from ASRS also include a quick-response program for CRAO, and trials of agents for GA and mydriasis reversal.